2023-03-30T16:58:22+08:00 weekly 1.0 https://af.prisysbiotech.com/ 2024-11-11T23:41:33+08:00 weekly 0.9 https://af.prisysbiotech.com/animal-welfare 2024-11-11T23:41:42+08:00 weekly 0.9 https://af.prisysbiotech.com/ophthalmic-disease-research 2024-11-11T23:41:31+08:00 weekly 0.9 https://af.prisysbiotech.com/translational-research-center 2024-11-11T23:41:41+08:00 weekly 0.9 https://af.prisysbiotech.com/metabolic-syndromes-research 2024-11-11T23:41:39+08:00 weekly 0.9 https://af.prisysbiotech.com/respiratory-disease-research 2023-04-01T04:23:03+08:00 weekly 0.9 https://af.prisysbiotech.com/co-develop 2024-11-11T23:41:41+08:00 weekly 0.9 https://af.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-11T23:41:43+08:00 weekly 0.9 https://af.prisysbiotech.com/inflammation-immunology-disorders 2024-11-11T23:41:36+08:00 weekly 0.9 https://af.prisysbiotech.com/hematological-disease-research 2024-11-11T23:41:24+08:00 weekly 0.9 https://af.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://af.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://af.prisysbiotech.com/fibrosis 2024-11-11T23:41:30+08:00 weekly 0.9 https://af.prisysbiotech.com/about-us 2024-11-11T23:41:30+08:00 weekly 0.9 https://af.prisysbiotech.com/contact-us 2023-04-01T04:23:02+08:00 weekly 0.9 https://af.prisysbiotech.com/newslist-1 2024-11-11T23:41:29+08:00 weekly 0.9 https://af.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://af.prisysbiotech.com/blog/ 2023-04-01T04:06:41+08:00 weekly 0.9 https://af.prisysbiotech.com/translation-research/ 2023-04-01T04:06:41+08:00 weekly 0.9 https://af.prisysbiotech.com/safety-evaluation/ 2023-04-01T04:06:41+08:00 weekly 1.0 https://af.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T04:06:42+08:00 weekly 0.9 https://af.prisysbiotech.com/biosafety-research/ 2023-04-01T04:06:43+08:00 weekly 0.9 https://af.prisysbiotech.com/pk-pd-adme/ 2024-04-08T20:18:10+08:00 weekly 0.9 https://af.prisysbiotech.com/clearpoint/ 2024-11-11T23:41:46+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-04-01T04:22:53+08:00 weekly 0.8 https://af.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-04-01T04:22:55+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-11T23:41:32+08:00 weekly 0.8 https://af.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-11T23:41:28+08:00 weekly 0.8 https://af.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-04-01T04:22:55+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-11T23:41:40+08:00 weekly 0.8 https://af.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-04-01T04:22:55+08:00 weekly 0.8 https://af.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-12T00:10:06+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-11T23:41:34+08:00 weekly 0.8 https://af.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-11T23:41:40+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-11T23:41:32+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-04-01T04:22:58+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-04-01T04:22:59+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-11T23:41:26+08:00 weekly 0.8 https://af.prisysbiotech.com/translation-research/nhpresources.html 2023-04-01T04:22:58+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-11T23:41:36+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-04-01T04:22:58+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-11T23:41:40+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-11T23:41:31+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-11T23:41:33+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T04:22:59+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-04-01T04:22:55+08:00 weekly 0.8 https://af.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-11T23:41:32+08:00 weekly 0.8 https://af.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-11T23:41:31+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-11T23:41:26+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-04-01T04:22:58+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-11T23:41:35+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-04-01T04:23:00+08:00 weekly 0.8 https://af.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-11T23:41:30+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-11T23:41:33+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-11T23:41:44+08:00 weekly 0.8 https://af.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-11T23:41:48+08:00 weekly 0.8 https://af.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-11T23:41:36+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-11T23:41:50+08:00 weekly 0.8 https://af.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T14:02:10+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:02:12+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T14:02:15+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:02:16+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-11-11T23:41:43+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:02:21+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T14:02:26+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-07T20:15:09+08:00 weekly 0.8 https://af.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-07T23:20:24+08:00 weekly 0.8 https://af.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-06T18:24:24+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-06T18:24:40+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-20T08:03:18+08:00 weekly 0.8 https://af.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-20T08:03:19+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-21T08:18:08+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T15:49:22+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T08:41:03+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T02:41:30+08:00 weekly 0.8 https://af.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-01T19:42:11+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-26T00:47:05+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T20:12:00+08:00 weekly 0.8 https://af.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T04:22:50+08:00 weekly 0.9 https://af.prisysbiotech.com/newslist-714233-1 2023-04-01T04:22:50+08:00 weekly 0.9 https://af.prisysbiotech.com/newslist-714234-1 2024-07-29T16:26:00+08:00 weekly 0.9 https://af.prisysbiotech.com/newslist-818675-1 2023-04-01T04:22:52+08:00 weekly 0.8 https://af.prisysbiotech.com/news/meetprisys-sot2023-66126527.html 2023-04-01T04:22:53+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66126528.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-sot2023-66126529.html 2023-04-01T04:22:52+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66126530.html 2023-04-01T04:22:53+08:00 weekly 0.8 https://af.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66126531.html 2023-04-01T04:22:56+08:00 weekly 0.8 https://af.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66126532.html 2023-04-01T04:22:54+08:00 weekly 0.8 https://af.prisysbiotech.com/news/gene-therapy-nhp-model-66126533.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66126534.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66126535.html 2023-04-01T04:22:57+08:00 weekly 0.8 https://af.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66126536.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/gene-therapy-toxicology-66273722.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67540663.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67541625.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67543435.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67543436.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/world-parkinsons-disease-day-67543437.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67545449.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67551472.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67551473.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68118855.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68118857.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68118861.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68118863.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68321966.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69006714.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69006854.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69007026.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69007547.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69007964.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69016767.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309335.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309364.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309406.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309417.html 2023-08-01T17:17:32+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69656473.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69663324.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70978626.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70978627.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70978628.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70978629.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70978630.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/0-70978631.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321993.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321994.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321995.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321997.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321998.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72679295.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73021876.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73544299.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73544300.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74175770.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74678523.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74798442.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75171713.html 2024-11-11T23:41:26+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75171715.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76183105.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77063347.html 2024-11-11T23:41:27+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77721261.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77721263.html 2024-11-11T23:41:30+08:00 weekly 0.8 https://af.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185675.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185677.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185680.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-asthma-model-79185681.html 2024-11-11T23:41:28+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185688.html 2024-11-11T23:41:39+08:00 weekly 0.8 https://af.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410567.html 2024-11-11T23:41:34+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410568.html 2024-11-12T00:09:57+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410570.html 2024-11-11T23:41:39+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pk-strategies-of-pdc-79526880.html 2024-11-11T23:41:32+08:00 weekly 0.8 https://af.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526881.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526883.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79526884.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526885.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526886.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526887.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79526888.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526889.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526890.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79526891.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526892.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79526893.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526895.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79526896.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526897.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79526898.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526899.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526900.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79526902.html 2024-11-11T23:41:37+08:00 weekly 0.8 https://af.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526903.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526904.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79526905.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79526907.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79526908.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526909.html 2024-11-11T23:41:34+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526910.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526911.html 2024-11-11T23:41:38+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526912.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526913.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79526914.html 2024-11-11T23:41:34+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79526915.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79526917.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526920.html 2024-11-11T23:41:34+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mrna-based-therapies-past-79526921.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79526922.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526924.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79526925.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79526926.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79526927.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/significance-principles-and-requirements-of-79526928.html 2024-11-11T23:41:33+08:00 weekly 0.8 https://af.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79526929.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mrna-based-therapies-present-79526930.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79526931.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79526932.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79526933.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79526941.html 2024-08-07T08:44:33+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656471.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120367.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/china-experimental-monkey-industry-81120368.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120369.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120370.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120371.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-models-of-human-diseases-81120372.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120373.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/human-disease-animal-models-81120375.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120377.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120378.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/compartment-pk-model-81120380.html 2024-11-11T23:41:40+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120797.html 2024-11-11T23:41:37+08:00 weekly 0.8 https://af.prisysbiotech.com/news/convection-enhanced-delivery-81120798.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82331167.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82790203.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82790205.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82790206.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82790207.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82790208.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82790212.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82790215.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82790218.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82790960.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83027329.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83028241.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83030663.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84038469.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84038471.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84038472.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84038473.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84038477.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84038478.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84038481.html 2025-01-20T09:11:48+08:00 weekly 0.8 https://af.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84038491.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84038553.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245459286516736.html 2025-02-27T12:29:20+08:00 weekly 0.8 https://af.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245459534783488.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17302275002885120.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-models-for-womens-health-17302275045237760.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17302275057509376.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17302275146343424.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17302275165070336.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17302275178980352.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17302275182126080.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17302275226592256.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17302275250070528.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17302275281314816.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17302275289736192.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/membranous-nephropathy-model-17302275306234880.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17302275332269056.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17302275383010304.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17302275399361536.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17302275430605824.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17302390528074752.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17303146348372992.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17388309433230336.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17388309455217664.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17388309479678976.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17388309566759936.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/intracerebroventricular-icv-injection-17388309616092160.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17388309636654080.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17388309723603968.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17388309736514560.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17388309830149120.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17395301646410752.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17395301684765696.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17395339215971328.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17450300155520000.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17450300205114368.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17450300213044224.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17450300218778624.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17450300261065728.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17450300285019136.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17450300310856704.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/key-considerations-for-dosing-volume-17450300335694848.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17450300371117056.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17450300442731520.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17450300899877888.html 2025-07-20T08:41:17+08:00 weekly 0.8 https://af.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17450303184561152.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17495613117867008.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17495613168313344.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-copd-model-17495613169853440.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17495613176210432.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17495613290275840.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17495613351322624.html 2025-09-14T15:49:27+08:00 weekly 0.8 https://af.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530014248559616.html 2025-09-14T15:49:29+08:00 weekly 0.8 https://af.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530014307623936.html 2025-09-14T15:49:36+08:00 weekly 0.8 https://af.prisysbiotech.com/news/brain-targeted-drug-delivery-17530014312752128.html 2025-09-14T15:49:22+08:00 weekly 0.8 https://af.prisysbiotech.com/news/the-importance-of-administration-volume-17530014343848960.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530014366524416.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530014407926784.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530030971479040.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538103129252864.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17554363198366720.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625153124754432.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625153126278144.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625153139926016.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625153193370624.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625153257989120.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625153277142016.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625153316824064.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625153358816256.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625153412637696.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-renal-biopsy-17625153540072448.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625153553589248.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674947985531904.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674948039353344.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674948069041152.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674948077184000.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674948090209280.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674948097188864.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674948154860544.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674948194968576.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674948261225472.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724221905282048.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724221974684672.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724221993001984.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724221994066944.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724222030816256.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724222049707008.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724222169998336.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724222317519872.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724222496269312.html 2026-03-28T01:40:50+08:00 weekly 0.8 https://af.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724222646559744.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://af.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html